Afton Scientific Corporation

Afton Scientific Corporation

Afton Scientific was founded more than 20 years ago as a CDMO focused on aseptic manufacturing. Its headquarters and single facility are located in Charlottesville, Virginia. The firm serves global pharmaceutical clients but does not publicly disclose its ownership structure or specific founding year. The firm provides end-to-end contract manufacturing services, including aseptic processing, sterile filling, fill-finish operations, and quality assurance. It specializes in biologics, small molecules, and emerging modalities. The company emphasizes regulatory compliance with FDA (CBER and CDER) standards and maintains a Quality Management System. Services include analytical testing, stability studies, and quality control. The firm claims a 99.9% on-time delivery rate (per the firm's website, 2026). The facility operates as a single site in Charlottesville. The firm has launched a multi-year expansion plan that includes a new pre-filled syringe and cartridge filling line in 2026 and a new facility planned for 2028, which is expected to create over 200 jobs (per the firm, 2026). The company does not disclose team size, a separate foundation, or affiliated vehicles. Afton Scientific's structural differentiator is its focus on aseptic fill-finish manufacturing as a single-facility standalone business, not on managing third-party capital or investment portfolios. It operates as an operating company rather than a family office. No succession or governance details are publicly available.